SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003404
Filing Date
2024-02-12
Accepted
2024-02-12 17:15:08
Documents
1
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 form4-02122024_100201.html 4  
1 form4-02122024_100201.xml 4 3561
  Complete submission text file 0001415889-24-003404.txt   5100
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Maynard Ryan D (Reporting) CIK: 0001363984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 24621254